State of Alaska Department of Revenue Invests $2.63 Million in Hims & Hers Health, Inc. (NYSE:HIMS)

State of Alaska Department of Revenue acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 108,700 shares of the company's stock, valued at approximately $2,628,000.

Other large investors have also recently made changes to their positions in the company. Crewe Advisors LLC acquired a new position in Hims & Hers Health during the fourth quarter valued at $28,000. Raleigh Capital Management Inc. raised its position in shares of Hims & Hers Health by 1,100.0% in the fourth quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company's stock worth $29,000 after acquiring an additional 1,100 shares during the period. GAMMA Investing LLC raised its position in shares of Hims & Hers Health by 2,173.7% in the fourth quarter. GAMMA Investing LLC now owns 2,251 shares of the company's stock worth $54,000 after acquiring an additional 2,152 shares during the period. Quest Partners LLC raised its position in shares of Hims & Hers Health by 22.6% in the third quarter. Quest Partners LLC now owns 4,373 shares of the company's stock worth $81,000 after acquiring an additional 807 shares during the period. Finally, CWM LLC increased its stake in shares of Hims & Hers Health by 21.4% during the third quarter. CWM LLC now owns 5,982 shares of the company's stock worth $110,000 after purchasing an additional 1,054 shares in the last quarter. 63.52% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, COO Melissa Baird sold 67,687 shares of the firm's stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $44.71, for a total transaction of $3,026,285.77. Following the transaction, the chief operating officer now directly owns 706,872 shares of the company's stock, valued at approximately $31,604,247.12. This trade represents a 8.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Oluyemi Okupe sold 11,581 shares of the firm's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $43.01, for a total transaction of $498,098.81. Following the transaction, the chief financial officer now directly owns 107,789 shares in the company, valued at $4,636,004.89. The trade was a 9.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,111,554 shares of company stock valued at $33,865,763 in the last ninety days. Insiders own 17.71% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. BTIG Research assumed coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They set a "buy" rating and a $35.00 target price for the company. Piper Sandler boosted their target price on shares of Hims & Hers Health from $21.00 to $24.00 and gave the stock a "neutral" rating in a research note on Monday, January 6th. TD Cowen reissued a "buy" rating and set a $28.00 target price on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Canaccord Genuity Group boosted their target price on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a "buy" rating in a research note on Monday, December 2nd. Finally, Citigroup cut shares of Hims & Hers Health from a "neutral" rating to a "sell" rating and increased their price target for the company from $24.00 to $25.00 in a research note on Friday, January 10th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $25.13.

Hims & Hers Health Trading Up 2.1 %

Shares of NYSE HIMS traded up $1.23 during mid-day trading on Friday, reaching $60.41. The company had a trading volume of 38,691,338 shares, compared to its average volume of 13,686,256. The firm has a 50 day simple moving average of $32.06 and a two-hundred day simple moving average of $24.26. The stock has a market cap of $13.20 billion, a P/E ratio of 137.31 and a beta of 1.35. Hims & Hers Health, Inc. has a 52-week low of $9.22 and a 52-week high of $64.84.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.